Page last updated: 2024-11-05

trihexyphenidyl and Vitamin D Deficiency

trihexyphenidyl has been researched along with Vitamin D Deficiency in 1 studies

Trihexyphenidyl: One of the centrally acting MUSCARINIC ANTAGONISTS used for treatment of PARKINSONIAN DISORDERS and drug-induced extrapyramidal movement disorders and as an antispasmodic.

Vitamin D Deficiency: A nutritional condition produced by a deficiency of VITAMIN D in the diet, insufficient production of vitamin D in the skin, inadequate absorption of vitamin D from the diet, or abnormal conversion of vitamin D to its bioactive metabolites. It is manifested clinically as RICKETS in children and OSTEOMALACIA in adults. (From Cecil Textbook of Medicine, 19th ed, p1406)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Sharma, A1
Sinha, S1
Narang, A1
Chouhan, DK1
Gupta, S1

Other Studies

1 other study available for trihexyphenidyl and Vitamin D Deficiency

ArticleYear
Waddling Gait: A complication of valproate therapy and a thought beyond vitamin D deficiency.
    Sultan Qaboos University medical journal, 2020, Volume: 20, Issue:1

    Topics: Adolescent; Anticonvulsants; Antipsychotic Agents; Drug Therapy, Combination; Epilepsy, Absence; Fem

2020